OA
GSK icon

OFI Advisors’s GSK GSK Stock Holding History

OFI Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$153K Buy
3,180
+60
+2% +$3.12K 0.01% 1322
2015
Q2 		$162K Buy
3,120
+494
+19% +$27.8K 0.01% 1334
2015
Q1 		$152K Sell
2,626
-109
-4% -$6.25K 0.01% 1355
2014
Q4 		$146K Buy
2,735
+253
+10% +$14.2K 0.01% 1356
2014
Q3 		$143K Buy
2,482
+240
+11% +$14.7K 0.01% 1323
2014
Q2 		$150K Buy
2,242
+8
+0.4% +$541 0.01% 1302
2014
Q1 		$149K Sell
2,234
-41
-2% -$2.77K 0.01% 1257
2013
Q4 		$152K Sell
2,275
-82
-3% -$5.32K 0.01% 1220
2013
Q3 		$148K Sell
2,357
-101
-4% -$6.5K 0.01% 1143
2013
Q2 		$154K Buy
+2,458
New +$156K 0.02% 1031

Other funds holding GSK

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

OFI Advisors's GSK Position: Q3 2015 in Review

OFI Advisors increased its GSK (GSK) stake by 1.9% in Q3 2015, buying an estimated $3.12K and bringing the position to 3,180 shares worth $153K. The position accounts for 0.01% of the portfolio, ranked #1322.

OFI Advisors first reported a position in GSK in Q2 2013 and has held it in 10 quarters since. The position peaked at $162K in Q2 2015. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

  • OFI Advisors held 3,180 shares of GSK worth $153K as of Q3 2015.
  • OFI Advisors bought 60 GSK shares in Q3 2015, an estimated $3.12K.
  • GSK made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1322 holding.
  • OFI Advisors first reported a position in GSK in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's GSK position peaked at $162K in Q2 2015.
  • 706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.